01:24 PM EST - Doseology Sciences Inc : Announces the successful soft launch of seven new adaptogenic mushroom products in the United States, and the upcoming launch of the product line in the Canadian market during the first quarter of 2022. Doseology's new medicinal mushroom products have successfully completed test marketing with overwhelmingly positive ratings and reviews, being among the most comprehensive available on the market. Doseology Sciences Inc
shares C.MOOD are trading unchanged at $0.18.
